Oppenheimer raises Neurocrine Biosciences price target on acquisition

Cevap yazmak için giriş yap yada kayıt ol.
Benzer konular Forum Tarih
A Oppenheimer maintains Immunovant stock rating on next-gen drug focus Hisse Senetleri 0 9
A Oppenheimer raises Ionis Pharmaceuticals price target on pricing move Hisse Senetleri 0 8
A Tandem Diabetes at Oppenheimer Conference: Strategic Shift to Pharmacy Hisse Senetleri 0 19
A Oppenheimer reiterates Abeona Therapeutics stock rating at Outperform Hisse Senetleri 0 15
A Evolent Health at Oppenheimer Conference: Strategic Growth and Financial Focus Hisse Senetleri 0 13
A Oppenheimer raises Nektar Therapeutics price target to $140 Hisse Senetleri 0 12
A Oppenheimer reiterates Perform on Adobe stock amid CEO transition Hisse Senetleri 0 15
A Oppenheimer raises Biogen stock price target to $250 on long-term growth outlook Hisse Senetleri 0 18

Benzer konular

Üst